Loading stock data…
DaVita Inc. (DVA)
$219.70+2.66 (+1.23%)
Market ClosedLast close Jun 29
DaVita Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
DaVita Inc. in the Healthcare sector is trading at $219.70 with a market capitalization of $14.1B. Wall Street consensus targets $193.71 (7 analysts), implying a -11.8% move over the next 12 months. The stock is currently near its 52-week high of $221.59, remaining 51.8% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -11.8% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.42B↓ | $3.62B↑ | $3.42B↑ | $3.38B↑ | $3.22B |
| Gross Profit | $1.07B↓ | $1.21B↑ | $1.09B↓ | $1.12B↑ | $983.87M |
| Operating Income | $473.55M↓ | $551.21M↑ | $495.61M↓ | $530.48M↑ | $433.33M |
| Net Income | $197.53M↓ | $234.22M↑ | $150.33M↓ | $199.34M↑ | $162.92M |
Peer Comparison
JNJUNHPFE
Fundamentals
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpa...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.10B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.19
Beta
Defensive asset. Lower volatility than the S&P 500.
0.91
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-103.43%
Volume
Today's trading volume
749,906
Recent News
Is Alignment Healthcare (ALHC) Stock Outpacing Its Medical Peers This Year?
Here is how Alignment Healthcare (ALHC) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Why the Market Dipped But DaVita HealthCare (DVA) Gained Today
In the most recent trading session, DaVita HealthCare (DVA) closed at $217.04, indicating a +1.72% shift from the previous trading day.
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
If You Own These 10 Stocks — Analysts Think You Should Sell Them
Analysts don't like to put "sell" ratings on S&P 500 stocks. So the fact they're willing to do it with some is worth your attention.
Best Growth Stocks to Buy for June 26th
LYB, HRB and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26th, 2026.